Subchronic effects of oxodipine, a calcium channel blocker affecting the adrenal gland of the dog, are described. Thirteen wk of treatment at a high dose (24 mg/kg/day) of oxodipine resulted in drug-induced thickening of the zona glomerulosa and increased stimulation of its secretory activity. It is postulated that subchronic administration of oxodipine at this dosage resulted in a decrease in blood pressure, with uninterrupted stimulation of the adrenal zona glomerulosa to release aldosterone, causing an increase in the width of this portion of the gland involving cellular hyperplasia. Support for this indirect effect is found in the increased presence of renin granules in the juxtaglomerular apparatus.
Davis DA and Medline MN (1970). Spironolactone (adactone) bodies: Concentric lamellar formations in the adrenal cortex of patients treated with spirolactone. Am. J. Clin. Pathol. 54: 22-32.
2.
Domenici Lombardo LD and Cortesini C. (1988). The zona glomerulosa of the adrenal gland in rats with porta-caval shunt. An ultrastructural and morphometric study. Int. J. Exp. Pathol.71: 639-646.
3.
Finkel MS, Aguilera G., Catt KJ, and Keisser HR (1984). [3H] nitredipine binding to the adrenal capsular membrane. Life Sci. 35: 905-910.
4.
Galiano A. (1987). Oxodipine. Drugs of the Future12: 633-635.
5.
Ganguly A., Chiou S., and Davis JS (1990). Intracellular mediators of potassium-induced aldosterone secretion. Life Sci. 46: 173-180.
6.
Gopinath G., Prentice DE, and Lewis DJ (1987). Atlas of Experimental Toxicological Pathology . MTP Press Limited, Lancaster , Boston, The Hague, Dordrecht , p. 104.
7.
Krebs R. (1983). Adverse reactions with calcium channel antagonists . Hypertension5: 11125-11129.
8.
Mazzocchi G. , Malendowicz LK, Rebuffat P., Robba C., Gottardo G., and Nussdorfer GG (1986). Short-and long-term effects of ACTH on the adrenal zona glomerulosa of the rat. A coupled stereological and enzymogical study. Cell Tissue Res. 243: 303-310.
9.
Mazzocchi G. , Robba C., Rebuffat P., and Nussdorfer GG (1986). Effects of prolactin administration of the zona glomerulosa of the rat adrenal cortex: Sterology and plasma hormone concentrations. Acta Endocrinol. Copenhagen111: 101-105.
10.
Murad F. (1990). Drugs used in the treatment of angina: Calcium channel blockers. In: The Pharmacological Basis of Therapeutics , 8th ed., AG Gilman, TW Rall, AS Nies, and P Taylor (eds.). Pergamon Press, New York, pp. 800-808.
11.
Nichols J. and Hennigar G. (1964). Effects of pulmonary hypertension on adrenal and kidney of dogs infected with heart worms (Dirofilaria immitis). Lab. Invest. 13: 800-808.
12.
Nussdorfer GG, Kasprzak A., Mazzocchi G., Rebuffat P., Malendowicz LK, and Robba C. (1986). Short- and long-term effects of angiotensin II on the rat adrenal zona glomerulosa . A coupled stereological and enzymological study. Exp. Clin. Endocrinol. 88: 157-164.
13.
Nyska A., Waner T., Scolnik M., Zukerman S., Pirak M., Keuhnberg W., and Gordon EB (1989). Quantitative evaluation of chlorotoluran-induced splenic hemosiderosis by means of an image analyzer. Vet. Human Toxicol. 31: 218-221.
14.
Rebuffat P. , Malendowicz LK, Belloni AS, Mazzocchi G., and Nussdorfer GG (1988). Long-term stimulatory effect of neuropeptide-Y on the growth and steroidogenic capacity of rat adrenal zonal glomerulosa. Neuropeptides11: 133-136.
15.
Robba C., Rebuffat P., Mazzocchi G., and Nussdorfer GG (1988). Long-term trophic action of alpha-melanocyte stimulating hormone on the zona glomerulosa of the rat adrenal cortex. Acta Endocrinol. Copenhagen112: 404.
16.
Thomas BL (1979). Drug induced lysosomal lipidosis: Biochemical interpretations. Pharmacol. Rev. 30: 593-603.
17.
Waner T., Nyska A., Nyska M., Sela M., Pirak M., and Galiano A. (1988). Gingival hyperplasia in dogs induced by oxodipine, a calcium channel blocker agent. Toxicol. Pathol. 16: 327-332.
